Purdue Pharma operating profit increases to $29 million in November

By Caroline Salls

Pittsburgh, Dec. 23 – Purdue Pharma LP posted a $29 million operating profit for November on $77 million in net sales, according to its monthly operating report filed Friday with the U.S. Bankruptcy Court for the District of Delaware.

In comparison, the company reported a $26 million operating profit for October on $79 million in net sales.

Net income for November was $66,000, up from $62,000 of October net income.

In addition, Purdue listed $1,177,000,000 in cash and cash equivalents as of Nov. 30, up from $1,145,000,000 at the end of October.

Purdue Pharma is a Stamford, Conn.-based drug manufacturer. It filed for Chapter 11 bankruptcy on Sept. 15 under case number 19-23649.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.